and will compare it to an historical control group of patients that have received drug-eluting stents through Medtronic’s prior clinical studies of its Resolute Onyx implant. Participants in ...

Rockville, MD, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The global peripheral stent implant market is set to be valued at US$ 4.11 billion in 2024 and is projected to expand at 6.6% CAGR from 2024 to 2034.

Peripheral vascular devices are of significant importance in the management and treatment of vascular diseases affecting veins and arteries other than the brain ones. These include stents ...

Medtronic announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.

Boston's coronary stent ... Medtronic, and Abbott hold more than 90% of the global CRM market, by our estimates. The presence of these top-tier competitors has remained unscathed by the peripheral ...

The growth of the stent graft balloon catheter market is primarily driven by the increasing prevalence of cardiovascular ...

The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...

The "Plaque Modification Devices - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The plaque modification devices market was valued ...

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final two rounds ...

Medtronic (NYSE:MDT) announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.